Cargando…
New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy
Around 0.75 million babies worldwide suffer from moderate or severe hypoxic-ischemic encephalopathy (HIE) each year resulting in around 400,000 babies with neurodevelopmental impairment. In 2010, neonatal HIE was associated with 2.4% of the total Global Burden of Disease. Therapeutic hypothermia (TH...
Autores principales: | Victor, Suresh, Rocha-Ferreira, Eridan, Rahim, Ahad, Hagberg, Henrik, Edwards, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897336/ https://www.ncbi.nlm.nih.gov/pubmed/34820702 http://dx.doi.org/10.1007/s00431-021-04320-8 |
Ejemplares similares
-
Neuroprotective Effects of Diabetes Drugs for the Treatment of Neonatal Hypoxia-Ischemia Encephalopathy
por: Poupon-Bejuit, Laura, et al.
Publicado: (2020) -
Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy
por: Rocha-Ferreira, Eridan, et al.
Publicado: (2018) -
Thiamine as a Possible Neuroprotective Strategy in Neonatal Hypoxic-Ischemic Encephalopathy
por: Sechi, Gian Pietro, et al.
Publicado: (2021) -
Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy
por: Dixon, Brandon J., et al.
Publicado: (2015) -
Hypoxic-Ischemic Neonatal Encephalopathy: Animal Experiments for Neuroprotective Therapies
por: Sameshima, Hiroshi, et al.
Publicado: (2013)